179 related articles for article (PubMed ID: 25277108)
1. Natural history of angiomyolipoma in lymphangioleiomyomatosis: implications for screening and surveillance.
Yeoh ZW; Navaratnam V; Bhatt R; McCafferty I; Hubbard RB; Johnson SR
Orphanet J Rare Dis; 2014 Oct; 9():151. PubMed ID: 25277108
[TBL] [Abstract][Full Text] [Related]
2. Lymphangioleiomyomatosis in patients with tuberous sclerosis: a national centre audit.
Johnson J; Somerfield W; Johnson SR
Orphanet J Rare Dis; 2024 Mar; 19(1):137. PubMed ID: 38532450
[TBL] [Abstract][Full Text] [Related]
3. Natural history of incidental sporadic and tuberous sclerosis complex associated lymphangioleiomyomatosis.
Di Marco F; Terraneo S; Dias OM; Imeri G; Centanni S; Rinaldo RF; Giuliani L; Lesma E; Palumbo G; Wanderley M; Ribeiro Carvalho CR; Guedes Baldi B
Respir Med; 2020 Jul; 168():105993. PubMed ID: 32469709
[TBL] [Abstract][Full Text] [Related]
4. Selected case from the Arkadi M. Rywlin International Pathology Slide Seminar: Sporadic lymphangioleiomyomatosis.
Bisceglia M; D'Alessandro V; Simeone A; Ben-Dor D; Pasquinelli G
Adv Anat Pathol; 2010 Nov; 17(6):445-52. PubMed ID: 20966650
[TBL] [Abstract][Full Text] [Related]
5. Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis.
Smolarek TA; Wessner LL; McCormack FX; Mylet JC; Menon AG; Henske EP
Am J Hum Genet; 1998 Apr; 62(4):810-5. PubMed ID: 9529362
[TBL] [Abstract][Full Text] [Related]
6. Clinical features of lymphangioleiomyomatosis complicated by renal angiomyolipomas.
Mizushina Y; Bando M; Hosono T; Mato N; Nakaya T; Ishii Y; Yamasawa H; Sugiyama Y
Intern Med; 2011; 50(4):285-9. PubMed ID: 21325759
[TBL] [Abstract][Full Text] [Related]
7. Everolimus for renal angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: extension of a randomized controlled trial.
Bissler JJ; Kingswood JC; Radzikowska E; Zonnenberg BA; Frost M; Belousova E; Sauter M; Nonomura N; Brakemeier S; de Vries PJ; Berkowitz N; Miao S; Segal S; Peyrard S; Budde K
Nephrol Dial Transplant; 2016 Jan; 31(1):111-9. PubMed ID: 26156073
[TBL] [Abstract][Full Text] [Related]
8. Extrathoracic angiomyolipomas in lymphangioleiomyomatosis.
Maziak DE; Kesten S; Rappaport DC; Maurer J
Eur Respir J; 1996 Mar; 9(3):402-5. PubMed ID: 8729995
[TBL] [Abstract][Full Text] [Related]
9. [IMPORTANCE OF SCREENING FOR LUNG LYMPHANGIOLEIOMYOMATOSIS AMONG RENAL ANGIOMYOLIPOMA CASES].
Sakaguchi K; Oka S; Ogawa K; Nagamoto S; Kurosawa K; Urakami S; Okaneya T
Nihon Hinyokika Gakkai Zasshi; 2017; 108(4):188-193. PubMed ID: 30333440
[TBL] [Abstract][Full Text] [Related]
10. Lymphangioleiomyomatosis and multifocal micronodular pneumocyte hyperplasia in Japanese patients with tuberous sclerosis complex.
Tanaka M; Hirata H; Wataya-Kaneda M; Yoshida M; Katayama I
Respir Investig; 2016 Jan; 54(1):8-13. PubMed ID: 26718139
[TBL] [Abstract][Full Text] [Related]
11. [Pulmonary lymphangioleiomyomatosis (LAM)].
Theegarten D; Hager T
Pathologe; 2021 Feb; 42(1):35-39. PubMed ID: 33420570
[TBL] [Abstract][Full Text] [Related]
12. Angiomyolipoma rebound tumor growth after discontinuation of everolimus in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis.
Bissler JJ; Nonomura N; Budde K; Zonnenberg BA; Fischereder M; Voi M; Louveau AL; Herbst F; Bebin EM; Curatolo P; Zonta A; Belousova E
PLoS One; 2018; 13(9):e0201005. PubMed ID: 30192751
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the oestrogen response in an angiomyolipoma derived xenograft model.
Clements D; Asprey SL; McCulloch TA; Morris TA; Watson SA; Johnson SR
Endocr Relat Cancer; 2009 Mar; 16(1):59-72. PubMed ID: 18988705
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and clinical characteristics of lymphangioleiomyomatosis (LAM) in patients with tuberous sclerosis complex.
Moss J; Avila NA; Barnes PM; Litzenberger RA; Bechtle J; Brooks PG; Hedin CJ; Hunsberger S; Kristof AS
Am J Respir Crit Care Med; 2001 Aug; 164(4):669-71. PubMed ID: 11520735
[TBL] [Abstract][Full Text] [Related]
15. Tuberous Sclerosis Complex: State-of-the-Art Review with a Focus on Pulmonary Involvement.
von Ranke FM; Zanetti G; e Silva JL; Araujo Neto CA; Godoy MC; Souza CA; Mançano AD; Souza AS; Escuissato DL; Hochhegger B; Marchiori E
Lung; 2015 Oct; 193(5):619-27. PubMed ID: 26104489
[TBL] [Abstract][Full Text] [Related]
16. Estradiol and tamoxifen stimulate LAM-associated angiomyolipoma cell growth and activate both genomic and nongenomic signaling pathways.
Yu J; Astrinidis A; Howard S; Henske EP
Am J Physiol Lung Cell Mol Physiol; 2004 Apr; 286(4):L694-700. PubMed ID: 12922981
[TBL] [Abstract][Full Text] [Related]
17. Chromosome 16 loss of heterozygosity in tuberous sclerosis and sporadic lymphangiomyomatosis.
Yu J; Astrinidis A; Henske EP
Am J Respir Crit Care Med; 2001 Oct; 164(8 Pt 1):1537-40. PubMed ID: 11704609
[TBL] [Abstract][Full Text] [Related]
18. Mutational analysis of the tuberous sclerosis gene TSC2 in patients with pulmonary lymphangioleiomyomatosis.
Astrinidis A; Khare L; Carsillo T; Smolarek T; Au KS; Northrup H; Henske EP
J Med Genet; 2000 Jan; 37(1):55-7. PubMed ID: 10633137
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of Mosaic Tuberous Sclerosis Complex Using Next-Generation Sequencing of Subtle or Unusual Cutaneous Findings.
Treichel AM; Boeszoermenyi B; Lee CR; Moss J; Kwiatkowski DJ; Darling TN
JID Innov; 2023 Mar; 3(2):100180. PubMed ID: 36960317
[TBL] [Abstract][Full Text] [Related]
20. Sporadic lymphangioleiomyomatosis and tuberous sclerosis complex with lymphangioleiomyomatosis: comparison of CT features.
Avila NA; Dwyer AJ; Rabel A; Moss J
Radiology; 2007 Jan; 242(1):277-85. PubMed ID: 17105849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
